Efficacy and Safety of Frontline Treatment Options for ALK+ NSCLC
November 30th 2021Karen Reckamp, MD, and Jyoti Patel, MD, review currently available frontline treatment options for ALK+ advanced NSCLC and discuss updated efficacy and safety data from key clinical trials of these agents in advanced NSCLC.